Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 #eye #for #pharma

Posted On Jun 17 2017 by

#pharmaceutical industry overview 2013 # Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 Life sciences companies face unprecedented challenges as revenues come under pressure as a consequence of pricing pressures caused by healthcare reforms and austerity measures, increased competition, and challenges in bringing new drugs and other products to market. They are responding by focusing on growth opportunities in emerging markets, pursuing breakthrough innovation through collaboration with industry and academic partners, challenging and revolutionizing the traditional sales, marketing and research and development (R D) operating models and focusing on operational efficiency. Shifts in the behavior of patients …


2013 MDM Market Leaders: Top Pharmaceutical Distributors #pharmaceutical #companies #in #nyc

Posted On Jun 13 2017 by

#pharmaceutical distribution companies # Editor’s note: This article was provided by Adam J. Fein, Ph.D. founder and president of Pembroke Consulting, Inc. and one of the country’s foremost experts on pharmaceutical economics and channel strategy. He also writes the writes the popular and influential Drug Channels website and publishes an annual report on the pharmaceutical wholesaling industry. LATEST REPORT NOW AVAILABLE: Click here to download the 2013-2014 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Three companies generate about 85% of all revenues from drug distribution in the United States: AmerisourceBergen Corporation (NYSE:ABC). Cardinal Health, Inc. (NYSE:CAH). and McKesson Corporation …


Top 10 animal health companies of 2013 #pharma #consultant

Posted On Jun 10 2017 by

#leading pharmaceutical companies 2013 # Top 10 animal health companies of 2013 It is fascinating what has happened in the last couple of years in the animal health industry, which runs to $22 billion a year for animal drugs and vaccines and is expected to grow at 5.7% compound annual rate, faster than the market for human medicines. Zoetis ($ZTS) was spun off from Pfizer ($PFE) as the largest independent animal health company. M A action in recent months is remixing the players once again. Next year, Novartis ($NVS) will be off of this list, and based on current revenues, …


2013 MDM Market Leaders: Top Pharmaceutical Distributors #pliva #pharma

Posted On May 29 2017 by

#pharmaceutical distribution companies # Editor’s note: This article was provided by Adam J. Fein, Ph.D. founder and president of Pembroke Consulting, Inc. and one of the country’s foremost experts on pharmaceutical economics and channel strategy. He also writes the writes the popular and influential Drug Channels website and publishes an annual report on the pharmaceutical wholesaling industry. LATEST REPORT NOW AVAILABLE: Click here to download the 2013-2014 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Three companies generate about 85% of all revenues from drug distribution in the United States: AmerisourceBergen Corporation (NYSE:ABC). Cardinal Health, Inc. (NYSE:CAH). and McKesson Corporation …


Pharmaceutical Industry Outlook 2013, Life Sciences Industry Outlook 2013 #marksans #pharma

Posted On May 18 2017 by

#pharmaceutical industry overview 2013 # Biopharma Life Sciences Outlook 2013 What are the Biggest Challenges and Opportunities Facing the Biopharma Life Sciences Industry During the Next Year? Pharma executives need to carefully consider their approach as they work to improve health economics and patient outcomes. To address unyielding pricing pressures and the enhanced requirement for clinical innovation, pharma companies should calibrate their drug development life cycle to select drug candidates early in the life cycle based on efficacy and economics, provide the evidence for approval and favorable reimbursements, and maintain a strong market position through post-launch evidence. This is especially …


Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 #market #research #reports

Posted On May 18 2017 by

#pharmaceutical industry overview 2013 # Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 Life sciences companies face unprecedented challenges as revenues come under pressure as a consequence of pricing pressures caused by healthcare reforms and austerity measures, increased competition, and challenges in bringing new drugs and other products to market. They are responding by focusing on growth opportunities in emerging markets, pursuing breakthrough innovation through collaboration with industry and academic partners, challenging and revolutionizing the traditional sales, marketing and research and development (R D) operating models and focusing on operational efficiency. Shifts in the behavior of patients …


The top 10 pharma companies by 2013 revenue #astellas #pharma

Posted On May 17 2017 by

#top pharma companies 2013 # The top 10 pharma companies by 2013 revenue The earnings reports for the biggest of Big Pharma are all in. Bayer reported last week, making it possible to see how they stacked up as they came into the new year. There are no big surprises. Pfizer ($PFE) and Merck Co. ($MRK), with ongoing patent issues and reorganizations, saw their positions fall a couple of notches, and AbbVie ($ABBV), having been spun off from Abbott Laboratories ($ABT) at the beginning of the year, didn’t quite make the top 10. Its disappearance allowed Eli Lilly Co. ($LLY) …


Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 #pharmaceutical #industry #profile

Posted On May 2 2017 by

#pharmaceutical industry overview 2013 # Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 Life sciences companies face unprecedented challenges as revenues come under pressure as a consequence of pricing pressures caused by healthcare reforms and austerity measures, increased competition, and challenges in bringing new drugs and other products to market. They are responding by focusing on growth opportunities in emerging markets, pursuing breakthrough innovation through collaboration with industry and academic partners, challenging and revolutionizing the traditional sales, marketing and research and development (R D) operating models and focusing on operational efficiency. Shifts in the behavior of patients …


Pharmaceutical Industry Outlook 2013, Life Sciences Industry Outlook 2013 #big #pharma #jobs

Posted On May 2 2017 by

#pharmaceutical industry overview 2013 # Biopharma Life Sciences Outlook 2013 What are the Biggest Challenges and Opportunities Facing the Biopharma Life Sciences Industry During the Next Year? Pharma executives need to carefully consider their approach as they work to improve health economics and patient outcomes. To address unyielding pricing pressures and the enhanced requirement for clinical innovation, pharma companies should calibrate their drug development life cycle to select drug candidates early in the life cycle based on efficacy and economics, provide the evidence for approval and favorable reimbursements, and maintain a strong market position through post-launch evidence. This is especially …


2013 MDM Market Leaders: Top Pharmaceutical Distributors #jobs #pharmaceutical #industry

Posted On Apr 28 2017 by

#pharmaceutical distribution companies # Editor’s note: This article was provided by Adam J. Fein, Ph.D. founder and president of Pembroke Consulting, Inc. and one of the country’s foremost experts on pharmaceutical economics and channel strategy. He also writes the writes the popular and influential Drug Channels website and publishes an annual report on the pharmaceutical wholesaling industry. LATEST REPORT NOW AVAILABLE: Click here to download the 2013-2014 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Three companies generate about 85% of all revenues from drug distribution in the United States: AmerisourceBergen Corporation (NYSE:ABC). Cardinal Health, Inc. (NYSE:CAH). and McKesson Corporation …